Subscribe
People
4 min read

Wuffes Installs a Dealmaker as CEO Just as Its Retail Rollout Peaks

Wuffes named Jonny Purcell, a former Raymond James M&A adviser, as CEO on August 10th, replacing founder-led operations just after the brand landed in Petco, PetSmart and Pet Supermarket within a single year.

Published on
August 10, 2026
Wuffes Installs a Dealmaker as CEO Just as Its Retail Rollout Peaks

A bootstrapped dog-supplement brand that spent six years selling only online just finished landing in three of the country's biggest pet specialty chains in under four months. Now it's handing the chief executive title to a former Raymond James M&A adviser, not a merchandising or e-commerce veteran. The company frames the move as support for a wellness-portfolio expansion, but the hire's profile points to a different kind of next chapter.

Purcell moves from Raymond James adviser to Wuffes CEO

Wuffes named Jonny Purcell chief executive on August 10th, promoting him from the president role he took in May 2025. Purcell spent over a decade advising consumer brands, most recently as a director at Raymond James, where he worked with pet care companies on growth, M&A and capital raising, following earlier time at KPMG Corporate Finance.

Founders Sam Venning and Josh Savinson, who built Wuffes without outside funding starting in 2020, are stepping back from daily operations to board and advisory roles. The company says it has served more than 1.2 million dogs and crossed $100 million in annual sales, and it ranked 400th on the 2025 Inc. 5000 list with 1,002% three-year growth.

The leadership change follows a rapid retail sprint. Wuffes went nationwide at Petco and PetSmart within a single quarter, landing in more than 1,400 Petco stores on April 27th and over 1,300 PetSmart stores on June 25th, then added all 199 Pet Supermarket locations, on top of specialty accounts at Hollywood Feed and Pet Food Experts.

A dealmaker CEO hire is rarely just about operations

Bootstrapped brands that promote a banker to chief executive are usually signaling something about the balance sheet, not the product roadmap. Purcell's background is capital raising and M&A, not retail operations or supply chain, which is the skill set companies typically want in the room right before a growth-equity raise, a recapitalization, or a sale process.

Wuffes just finished converting a six-year DTC-only track record into physical distribution at three national chains inside four months, the kind of proof point that makes a wholesale-driven consumer brand attractive to private equity buyers and strategics alike. Founders moving to board seats while an M&A specialist takes the wheel is a common structure ahead of a transaction, though Wuffes has not announced one.

Purcell would also be stepping into a warmer market than the one Wuffes built in. Capstone Partners counted 18 announced or completed pet-sector deals through the first four months of 2026, more than double the 8 in the same window a year earlier, with strategic buyers behind 10 of those. General Mills, Colgate and Chewy have all written checks into premium, health-focused pet brands in that window, exactly the kind of deal Purcell's background is built for.

What comes next for a newly omnichannel wellness brand

The clearest thing to watch is whether Wuffes announces outside capital, a recapitalization, or a sale process in the next two to three quarters.

The second thing to watch is what the promised expansion into "complete pet wellness" actually turns out to mean. Wuffes' current lineup already spans calming, probiotic, allergy and multivitamin chews alongside its original joint franchise, so the portfolio described in the release is mostly already built. The real test is whether the pivot means genuinely new categories, such as dental or weight management, or a move into cats, since Wuffes has sold only dog products to date.

Third, watch whether other joint-health-first supplement brands follow the same leadership pattern as they hit similar retail milestones. A finance-background CEO replacing a founder-operator is a specific tell, and The Underbite will be tracking whether it shows up again at a comparable-scale competitor within the next year.

Source: Company release submitted to The Underbite

This news brief is based on a company-submitted announcement. The Underbite verifies claims where possible but cannot independently confirm all details.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
GoodVets Buys WellHaven's 40 Hospitals, Ending Its De Novo-Only Era
Funding & M&A
5 min read

GoodVets Buys WellHaven's 40 Hospitals, Ending Its De Novo-Only Era

GoodVets is acquiring WellHaven Pet Health's network of more than 40 hospitals, growing its footprint from 75 to 116 locations. The deal marks a shift from the de novo strategy that defined the General Atlantic-backed platform's first decade toward the acquisition-led growth every other scaled vet consolidator already runs on.

Read article
Read article
Dechra's Oral Cancer Pill Targets the Dogs Chemo Never Reaches
Launches
5 min read

Dechra's Oral Cancer Pill Targets the Dogs Chemo Never Reaches

Dechra is commercially launching Laverdia, the first FDA-approved oral treatment for canine lymphoma, developed by Anivive and licensed to Dechra in 2022. The bet isn't on winning cases from oncology referral networks, but on treating the roughly 80% of diagnosed dogs who currently get no chemotherapy at all.

Read article
Read article
PetMeds Names New CEO, Rebuilds Board Amid Takeover Fight
People
5 min read

PetMeds Names New CEO, Rebuilds Board Amid Takeover Fight

PetMeds named Jeff Willard as its next CEO and added two new independent directors, including a Shake Shack executive as board chair, while a $3-a-share takeover bid from SilverCape Investments remains unanswered since June. None of the three new leaders has prior ties to the company, a signal the board is building outside credibility for whatever comes next.

Read article
View all articles